Valsts: Izraēla
Valoda: ivrits
Klimata pārmaiņas: Ministry of Health
PEGINTERFERON ALFA 2A 135 MCG / 0.5 ML
ROCHE PHARMACEUTICALS (ISRAEL) LTD
L03AB11
SOLUTION FOR INJECTION
S.C
HOFFMANN LA ROCHE LTD, SWITZERLAND
PEGINTERFERON ALFA-2A
Chronic Hepatitis B: Pegasys is indicated for the treatment of both HBeAg- positive and HBeAg -negative chronic hepatitis B in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.Chronic Hepatitis C: Pegasys is indicated for the treatment of chronic hepatitis C in adult patients who are positive for serum HCV-RNA including patients with compensated cirrhosis and/or co-infected with clinically stable HIV. The optimal way to use Pegasys in patients with chronic hepatitis C is in combination with ribavirin. The combination of Pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. Monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.
2013-09-01